These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10641280)

  • 41. Current status of the management of renal osteodystrophy.
    Fournier A; Sebert JL; Coevoet B; De Fremont JF; Hardin JM; Lambrey G
    Proc Eur Dial Transplant Assoc; 1978; 15():547-68. PubMed ID: 368790
    [No Abstract]   [Full Text] [Related]  

  • 42. [Studies on abnormalities of calcium, vitamin D and bone metabolism in patients on maintenance hemodialysis (author's transl)].
    Kitoh C
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):503-18. PubMed ID: 529620
    [No Abstract]   [Full Text] [Related]  

  • 43. The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.
    Zand L; Kumar R
    Endocrinol Metab Clin North Am; 2017 Dec; 46(4):983-1007. PubMed ID: 29080646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteodystrophy of dialysed patients treated with vitamin D.
    Verberckmoes R; Bouillon R; Krempien B
    Proc Eur Dial Transplant Assoc; 1973; 10(0):217-26. PubMed ID: 4370246
    [No Abstract]   [Full Text] [Related]  

  • 45. Vitamin D metabolites and their relationship to azotaemic osteodystrophy.
    Mason RS; Lissner D; Wilkinson M; Posen S
    Clin Endocrinol (Oxf); 1980 Oct; 13(4):375-85. PubMed ID: 7438480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Renal osteodystrophy-II-Recent therapeutic acquisitions (author's transl)].
    Sebert JL; Fournier AE; Gueris J; Marie P; Coevoet B; de Fremont JF; Lambrey G; Kuntz D
    Nouv Presse Med; 1977 Nov; 6(38):3533-7. PubMed ID: 341079
    [No Abstract]   [Full Text] [Related]  

  • 47. [Vitamin D metabolism and chronic kidney insufficiency].
    Schaefer K; von Herrath D; Kraft D
    Dtsch Med Wochenschr; 1973 Jul; 98(27):1338-44. PubMed ID: 4351844
    [No Abstract]   [Full Text] [Related]  

  • 48. [Therapy of uremic osteodystrophy].
    Fletti C; Docci D; Coli' L; Di Felice A
    G Clin Med; 1981 Apr; 62(4):270-9. PubMed ID: 7021295
    [No Abstract]   [Full Text] [Related]  

  • 49. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Lovinger RD; Mamunes P
    Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The investigation and treatment of renal osteodystrophy.
    Catto GR; MacLeod M; Pelc B; Kodicek E
    Proc Eur Dial Transplant Assoc; 1975; 11():473-80. PubMed ID: 1197272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proceedings: The use of metabolically-active derivatives of vitamin D in rickets and osteomalacia due to renal glomerular failure.
    Smith R; Henderson RG; Russell RG
    J Bone Joint Surg Br; 1975 May; 57(2):247-8. PubMed ID: 1141297
    [No Abstract]   [Full Text] [Related]  

  • 52. Increased bone turnover markers after renal transplantation.
    Grsković A; Celić T; Fuckar D; Markić D; Troselj M; Bobinac D
    Coll Antropol; 2010 Apr; 34 Suppl 2():145-8. PubMed ID: 21302713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Levels of plasma 1,25-dihydroxyvitamin D and parameters of phospho-calcium metabolism in children with non-dialyzed chronic renal failure].
    Loras B; Parchoux B; Durr F
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():755-60. PubMed ID: 6897703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 55. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis].
    Fournier A; Bordier P; Weil B; Safar M; Idatte JM
    Presse Med (1893); 1971 Oct; 79(45):2017-21. PubMed ID: 5119047
    [No Abstract]   [Full Text] [Related]  

  • 56. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 57. [Parathormone, calcitonin, 25-hydroxycalciferol and bone histology in patients with chronic renal insufficiency].
    Kokot F; Kuska J; Sledziński Z; Białas B; Luciak M
    Z Gesamte Inn Med; 1979 Nov; 34(22):665-70. PubMed ID: 549299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent clinical correlates of vitamin D metabolites and calcium metabolism.
    Nutr Rev; 1975 Jul; 33(7):209-10. PubMed ID: 1097964
    [No Abstract]   [Full Text] [Related]  

  • 59. The biochemical basis of renal osteodystrophy and post-menopausal osteoporosis: a view from the vitamin D system.
    DeLuca HF
    Curr Med Res Opin; 1981; 7(5):279-93. PubMed ID: 7014107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The metabolic fate of vitamin D3-3H in chronic renal failure.
    Avioli LV; Birge S; Lee SW; Slatopolsky E
    J Clin Invest; 1968 Oct; 47(10):2239-52. PubMed ID: 4300189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.